跳至主要内容
临床试验/ISRCTN14730035
ISRCTN14730035已完成3 期

Adjunct Low-Dose Ketamine Infusion versus Standard of Care in Mechanically Ventilated Critically Ill Patients at a Tertiary Saudi Hospital (ATTAINMENT Trial)

King Faisal Specialist Hospital & Research Centre0 个研究点目标入组 85 人开始时间: 2020年2月5日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
85

研究概览

简要总结

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32197636/ protocol (added 20/04/2020) 2021 Results article in https://doi.org/10.1186/s40560-021-00569-1 (added 01/09/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. ICU (Medical or surgical) patients (> 14 years old)
  • 2. Mechanically ventilated within the previous 24 hours and expected to remain intubated for more than 24 hours.
  • 3. Patient requires ongoing sedative medication
  • 4. No objection from the ICU attending MD for enrollment

排除标准

  • Current participant exclusion criteria as of 19/03/2020:
  • 1. Patients with a history of dementia or psychiatric disorders or on any anti-psychotics or anti-depressants medications at home
  • 2. Pregnancy
  • 3. Expected to need mechanical ventilation less than 24 hours
  • 4. Known hypersensitivity to ketamine
  • 5. Patient on dexmedetomidine as primary sedative agent prior to randomization
  • 6. Patients with cardiogenic shock, heart failure, myocardial infarction
  • 7. History of end-stage liver disease (Child Pugh score C)
  • 8. Proven or suspected primary neurological injury (traumatic brain injury, ischemic stroke, intracranial hemorrhage, spinal cord injury, anoxic brain injury)
  • 9. Patients with persistent heart rate (HR) > 150 bpm or systolic blood pressure (SBP) >180 mmHg
  • 10. Patients who assigned as do-not-resuscitate order (DNR) or expected to die within 24 h
  • 11. Patients on ECMO
  • 12. Patients with status epilepticus patients who are receiving the ketamine infusion for refractory status epilepticus
  • 13. Proven or suspected status asthmaticus
  • 14. Patients with expected targeted RASS of -5 such as patients on continuous infusion neuromuscular blockade
  • Previous participant exclusion criteria:
  • 1. Patients with a history of dementia or psychiatric disorders or on any anti-psychotics or anti-depressants medications at home
  • 2. Pregnancy
  • 3. Expected to need mechanical ventilation less than 24 hours
  • 4. Known hypersensitivity to ketamine
  • 5. Patient on dexmedetomidine as primary sedative agent prior to randomization
  • 6. Patients with cardiogenic shock, heart failure, myocardial infarction
  • 7. History of end-stage liver disease.
  • 8. Proven or suspected primary neurological injury (traumatic brain injury, ischemic stroke, intracranial hemorrhage, spinal cord injury, anoxic brain injury)
  • 9. Patients with persistent heart rate (HR) > 150 bpm or systolic blood pressure (SBP) >180 mmHg
  • 10. Patients who assigned as do-not-resuscitate order (DNR) or expected to die within 24 hours
  • 11. Patients on ECMO
  • 12. Patients with status epilepticus patients who are receiving the ketamine infusion for refractory status epilepticus
  • 13. Proven or suspected status asthmaticus

研究者

相似试验